Physician profile
Peter Pham
NPI 1104386853
$4,201.53
in general payments reported to CMS, 2019-2025
20 companies · $1,325 in 2025
The $1,325 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,955 · 2024: $922 · 2025: $1,325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,570 · Education: $1,135 · Travel and Lodging: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,569.75 |
| Education | $1,134.80 |
| Travel and Lodging | $496.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,888.21 | 2023-2024 | Senza |
| Boston Scientific Corporation | $708.71 | 2023-2025 | Intracept, General - Therapies, Superion Indirect Decompression System |
| Abbvie INC. | $250.51 | 2024-2025 | |
| Protega Pharmaceutials INC | $237.77 | 2025 | Roxybond |
| Vertos Medical, INC. | $184.80 | 2023-2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $131.87 | 2024-2025 | Belbuca, Xtampza |
| Averitas Pharma INC. | $115.44 | 2024-2025 | Qutenza |
| Abbott Laboratories | $112.61 | 2024-2025 | Eterna, Proclaim, Octrode |
| Medtronic, INC. | $109.79 | 2024-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Tersera Therapeutics LLC | $83.44 | 2024-2025 | Prialt |
| Curonix LLC | $79.53 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spinal Simplicity, LLC | $67.79 | 2025 | Ha Minuteman G3-R |
| Globus Medical, INC. | $53.38 | 2025 | Senza |
| Biotronik Nro, INC. | $41.96 | 2025 | Prospera |
| Atland Pharmaceuticals, LLC | $36.19 | 2025 | Tolmetin Sodium, Orphenadrine Citrate, Aspirin and Caffeine |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $26.03 | 2025 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $24.69 | 2025 | |
| Pfizer INC. | $21.75 | 2025 | |
| Convatec INC. | $16.97 | 2025 | |
| Saluda Medical Americas, INC. | $10.09 | 2023 | Evoke Scs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.